Home
>
National Drug Code (NDC)
>
Ceftazidime
Ceftazidime - 44567-235-25 - (Ceftazidime)
Drug Information of Ceftazidime
| Product NDC: | 44567-235 |
| Proprietary Name: | Ceftazidime |
| Non Proprietary Name: | Ceftazidime |
| Active Ingredient(s): | 1 g/20mL & nbsp; Ceftazidime |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ceftazidime
| Product NDC: | 44567-235 |
| Labeler Name: | WG Critical Care, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062640 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130131 |
Package Information of Ceftazidime
| Package NDC: | 44567-235-25 |
| Package Description: | 25 VIAL in 1 CARTON (44567-235-25) > 20 mL in 1 VIAL |
NDC Information of Ceftazidime
| NDC Code | 44567-235-25 |
| Proprietary Name | Ceftazidime |
| Package Description | 25 VIAL in 1 CARTON (44567-235-25) > 20 mL in 1 VIAL |
| Product NDC | 44567-235 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ceftazidime |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20130131 |
| Marketing Category Name | ANDA |
| Labeler Name | WG Critical Care, LLC |
| Substance Name | CEFTAZIDIME |
| Strength Number | 1 |
| Strength Unit | g/20mL |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |
